Get To Know Our Large-Scale CDMO
Operating out of a 475,000-square-foot, large-scale cGMP and FDA-guided manufacturing facility in Bristol, Tennessee, UPM combines the robust track record of a large pharmaceutical supplier with the agility of an independent, family-owned US-based CDMO. For our customers, this translates to exceptional quality and reliability — and a level of personalized service not often seen in a large pharma company in the US.
Beyond our expertise and technology, UPM is a contract manufacturing organization that has a passion for propelling our customers’ journeys to market, even when the journey doesn’t begin with us. As a large-scale CDMO, technology transfer and scale-up are our specialties; we welcome the opportunity to sit down with you to create a pharma solution by understanding the evolution of your project, your commercial goals, and how we can work together to get your product across the finish line.
To advance our customers’ formulation development efforts to the fullest extent possible, with the ultimate goal of commercialization, while adhering to strict standards of quality, timeliness, scientific principles and budget.
UPM Pharmaceuticals, Inc. originated as a drug formulation and cGMP laboratory within the University of Maryland School of Pharmacy, a recognized leader in industrial pharmaceutical innovation and education. Initially funded by an FDA contract to support the development of the Scale-Up & Post ApprovalChanges (SUPAC) guidelines in the early 1990s, it later became the independent organization of UPM pharmaceuticals, now a provider of technology transfer, cGMP manufacturing and analytical services. As a life science company, we continue this legacy of intellectual distinction and uncompromising performance with every new project. The talent and experience of our team, our dedication to science-based formulation design and our commitment to communication and timeliness have enabled us to offer the highest level of customized drug development services to our clients, from concept through commercialization.